Cambridge Investment Research Advisors, Inc. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$223
+134.7%
13,741
+35.9%
0.00%
Q4 2022$95
-99.7%
10,113
-6.5%
0.00%
Q3 2022$29,000
-12.1%
10,814
-4.4%
0.00%
Q2 2022$33,000
-2.9%
11,3130.0%0.00%
Q1 2022$34,000
-34.6%
11,3130.0%0.00%
Q4 2021$52,000
-25.7%
11,313
+1.8%
0.00%
Q3 2021$70,000
+7.7%
11,113
+1.7%
0.00%
Q2 2021$65,000
-27.0%
10,928
-22.3%
0.00%
Q1 2021$89,000
-37.3%
14,063
-1.5%
0.00%
-100.0%
Q1 2019$142,00014,2750.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 622,249$10,360,4463.42%
GREAT POINT PARTNERS LLC 1,000,000$16,650,0003.27%
Ghost Tree Capital, LLC 600,000$9,990,0002.95%
SILVERARC CAPITAL MANAGEMENT, LLC 380,000$6,327,0002.61%
Integral Health Asset Management, LLC 727,100$12,106,2152.44%
Sio Capital Management, LLC 250,000$4,162,5002.06%
Boxer Capital, LLC 2,000,000$33,3001.64%
DAFNA Capital Management LLC 319,155$5,313,9311.59%
5AM Venture Management, LLC 350,000$5,827,5001.49%
Monashee Investment Management LLC 300,000$4,995,0001.38%
View complete list of VIKING THERAPEUTICS INC shareholders